Platelet Aggregation Devices Market Size, Share, Industry Trends and Forecast to 2030

Platelet Aggregation Devices Market Size & CAGR in 2021:

The global platelet aggregation devices market is expected to witness a Compound Annual Growth Rate (CAGR) of 5.2% from 2021 to 2028. The market size is projected to reach USD 340 million by the end of 2028. Platelet aggregation devices are medical tools used to assess platelet function in patients, especially those with bleeding disorders or cardiovascular diseases.

COVID-19 Impact on the Platelet Aggregation Devices Market:

The COVID-19 pandemic has had a mixed impact on the platelet aggregation devices market. On one hand, the increased focus on healthcare and diagnosis during the pandemic has led to a rise in the demand for platelet aggregation devices. However, disruptions in the supply chain and reduced hospital visits for non-urgent cases have negatively affected market growth.

Platelet Aggregation Devices Dynamics:

The platelet aggregation devices market is primarily driven by the rising prevalence of cardiovascular diseases and the increasing adoption of point-of-care testing devices. Technological advancements in platelet aggregation devices, along with the growing geriatric population, are also contributing to market growth. However, challenges such as high costs of devices and lack of skilled professionals may hamper market expansion.

Segments and Related Analysis:

The platelet aggregation devices market can be segmented based on product type, application, end-user, and region. Product types include optical aggregometers, impedance aggregometers, and others. Applications of platelet aggregation devices include platelet function testing, platelet inhibition testing, and others. End-users of these devices are hospitals, diagnostic centers, research laboratories, and others.

By Region Analysis:

In terms of regional analysis, North America holds the largest share of the platelet aggregation devices market, followed by Europe and Asia Pacific. The presence of key market players, advanced healthcare infrastructure, and increasing investment in research and development activities are driving market growth in these regions.

Key Market Players and Competitive Landscape:

Some of the key players in the platelet aggregation devices market include Siemens Healthineers, Helena Laboratories, F.Hoffmann-La Roche Ltd, Aggredyne, Inc., Bio/Data Corporation, Chrono-log Corporation, Helena Biosciences Europe, and Haemonetics Corporation. These companies are focusing on product innovations, strategic collaborations, and mergers to strengthen their market presence.

Recent Happenings in the Platelet Aggregation Devices Market:

In recent developments, Siemens Healthineers introduced a new platelet aggregation device with enhanced sensitivity and specificity for diagnosing platelet disorders. Helena Laboratories collaborated with a leading research institute to develop a novel platelet aggregation assay for assessing drug efficacy in patients with thrombotic disorders. These advancements highlight the ongoing efforts to improve diagnostic capabilities in the platelet aggregation devices market.